Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chemotherapy-Induced Cognitive Impairment Is Associated with Cytokine Dysregulation and Disruptions in Neuroplasticity
Dongdong Shi, Yuhua Huang, Cora Sau Wan Lai, et al.
Molecular Neurobiology (2018) Vol. 56, Iss. 3, pp. 2234-2243
Closed Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

Mechanisms of Chemotherapy-Induced Neurotoxicity
Halina Waś, Agata Borkowska, Ana Bagüés, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 129
Cognitive impairment after cancer treatment: mechanisms, clinical characterization, and management
Ben Fleming, Paul Edison, Laura Kenny
BMJ (2023), pp. e071726-e071726
Closed Access | Times Cited: 42
Cellular mechanisms and treatments for chemobrain: insight from aging and neurodegenerative diseases
Lien D. Nguyen, Barbara E. Ehrlich
EMBO Molecular Medicine (2020) Vol. 12, Iss. 6
Open Access | Times Cited: 125
Plausible biochemical mechanisms of chemotherapy-induced cognitive impairment (“chemobrain”), a condition that significantly impairs the quality of life of many cancer survivors
Xiaojia Ren, Diana Boriero, Luksana Chaiswing, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2019) Vol. 1865, Iss. 6, pp. 1088-1097
Open Access | Times Cited: 99
Chemotherapy-Induced Cognitive Impairment Is Associated with Increased Inflammation and Oxidative Damage in the Hippocampus
Ciara Bagnall-Moreau, Sovira Chaudhry, Kaliris Y. Salas-Ramirez, et al.
Molecular Neurobiology (2019) Vol. 56, Iss. 10, pp. 7159-7172
Open Access | Times Cited: 92
Microglia in Cancer Therapy-Related Cognitive Impairment
Erin M. Gibson, Michelle Monje
Trends in Neurosciences (2021) Vol. 44, Iss. 6, pp. 441-451
Open Access | Times Cited: 75
Doxorubicin chemotherapy-induced “chemo-brain”: Meta-analysis
Sarah Eide, Zhong‐Ping Feng
European Journal of Pharmacology (2020) Vol. 881, pp. 173078-173078
Closed Access | Times Cited: 66
Pathogenesis, Assessments, and Management of Chemotherapy-Related Cognitive Impairment (CRCI): An Updated Literature Review
Longqin Lv, Shanping Mao, Huimin Dong, et al.
Journal of Oncology (2020) Vol. 2020, pp. 1-11
Open Access | Times Cited: 54
Chemobrain: A review on mechanistic insight, targets and treatments
Vanishree Rao, Rashmi Bhushan, Priyanka Kumari, et al.
Advances in cancer research (2022), pp. 29-76
Closed Access | Times Cited: 30
L-carnitine Modulates Cognitive Impairment Induced by Doxorubicin and Cyclophosphamide in Rats; Insights to Oxidative Stress, Inflammation, Synaptic Plasticity, Liver/brain, and Kidney/brain Axes
Olivia Fayez Morid, Esther T. Menze, Mariane G. Tadros, et al.
Journal of Neuroimmune Pharmacology (2023) Vol. 18, Iss. 3, pp. 310-326
Open Access | Times Cited: 16
An Overview on Chemotherapy-induced Cognitive Impairment and Potential Role of Antidepressants
Ankit Das, Niraja Ranadive, Manas Kinra, et al.
Current Neuropharmacology (2020) Vol. 18, Iss. 9, pp. 838-851
Open Access | Times Cited: 46
Emerging mechanistic underpinnings and therapeutic targets for chemotherapy-related cognitive impairment
Erin M. Gibson, Michelle Monje
Current Opinion in Oncology (2019) Vol. 31, Iss. 6, pp. 531-539
Open Access | Times Cited: 45
Chemobrain in rats: Behavioral, morphological, oxidative and inflammatory effects of doxorubicin administration
C.V. Cardoso, Marcelo P. Barros, André Luís Lacerda Bachi, et al.
Behavioural Brain Research (2019) Vol. 378, pp. 112233-112233
Closed Access | Times Cited: 44
Cancer Chemotherapy Related Cognitive Impairment and the Impact of the Alzheimer’s Disease Risk Factor APOE
Harvey R. Fernandez, Ashima Varma, Sarah A. Flowers, et al.
Cancers (2020) Vol. 12, Iss. 12, pp. 3842-3842
Open Access | Times Cited: 42
Relationship between cytokines and brain-derived neurotrophic factor (BDNF) in trajectories of cancer-related cognitive impairment
Ning Yi Yap, Yi Long Toh, Chia Jie Tan, et al.
Cytokine (2021) Vol. 144, pp. 155556-155556
Open Access | Times Cited: 37
Piperlongumine as a Neuro-Protectant in Chemotherapy Induced Cognitive Impairment
Fabio Ntagwabira, Madison Trujillo, Taylor McElroy, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 2008-2008
Open Access | Times Cited: 23
Atrazine Inhalation Causes Neuroinflammation, Apoptosis and Accelerating Brain Aging
Tiziana Genovese, Rosalba Siracusa, Roberta Fusco, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 7938-7938
Open Access | Times Cited: 30
An update on neurobiological mechanisms involved in the development of chemotherapy-induced cognitive impairment (CICI)
Laura Catalina Murillo, Jhon Jairo Sutachan, Sonia Luz Albarracín
Toxicology Reports (2023) Vol. 10, pp. 544-553
Open Access | Times Cited: 12
Alpha-Lipoic Acid Ameliorates Doxorubicin-Induced Cognitive Impairments by Modulating Neuroinflammation and Oxidative Stress via NRF-2/HO-1 Signaling Pathway in the Rat Hippocampus
Roshan Lal, Ravinder Naik Dharavath, Kanwaljit Chopra
Neurochemical Research (2023) Vol. 48, Iss. 8, pp. 2476-2489
Closed Access | Times Cited: 11
Roflumilast attenuates doxorubicin and cyclophosphamide combination-induced chemobrain in rats through modulation of NLRP3/ASC/caspase-1/GSDMD axis
Georgette Eskander, Sherihan G. AbdelHamid, Sara A. Wahdan, et al.
Life Sciences (2025) Vol. 362, pp. 123378-123378
Closed Access
The biological intersection between chemotherapy-related cognitive impairment and Alzheimer’s disease
Matthew Torre, Camila A. Zanella, Mel Β. Feany
American Journal Of Pathology (2025)
Open Access
α-Bisabolol alleviates doxorubicin-induced cognitive dysfunction in rats via enhancing the hippocampal BDNF/TrKB signaling and inhibiting neuroinflammation
Sara T. Elazab, Walter H. Hsu
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Chemobrain as a Product of Growing Success in Chemotherapy - Focus On Glia As Both A Victim And A Cure
Piotr Walczak, Mirosław Janowski
Neuropsychiatry (2019) Vol. 09, Iss. 01
Open Access | Times Cited: 30
Electroacupuncture trigeminal nerve stimulation plus body acupuncture for chemotherapy-induced cognitive impairment in breast cancer patients: An assessor-participant blinded, randomized controlled trial
Zhang-Jin Zhang, Sui‐Cheung Man, Lo-Lo Yam, et al.
Brain Behavior and Immunity (2020) Vol. 88, pp. 88-96
Closed Access | Times Cited: 28
Neurons as stromal drivers of nervous system cancer formation and progression
Corina Anastasaki, Yunqing Gao, David H. Gutmann
Developmental Cell (2023) Vol. 58, Iss. 2, pp. 81-93
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top